⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5617032 | 0.59 | — | — | |
| SCHEMBL9775476 | 0.56 | — | — | |
| N-Nitrosodimethylamine SCHEMBL4637228 | 0.56 | ALDH1A1 (1.00) | — | |
| N-Nitrosodimethylamine SCHEMBL686 | 0.56 | — | — | |
| SCHEMBL22537157 | 0.56 | — | — | |
| SCHEMBL167239 | 0.54 | — | — | |
| N-Nitrosodimethylamine SCHEMBL19971881 | 0.53 | — | — | |
| Ammonia Solution, Strong SCHEMBL20239094 | 0.50 | — | — | |
| Hydrochloric Acid SCHEMBL4025651 | 0.50 | — | — | |
| SCHEMBL462550 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080193380-A1 | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy | DALTON JAMES T | 2008-08-14 | — | — | US | claimed |
| EP-1641742-A4 | COMPOUNDS THAT SELECTIVELY BIND TO MEMBRANES OF APOPTOTIC CELLS | NST NEUROSURVIVAL TECHNOLOGIES (IL) | 2006-11-29 | — | — | EP | claimed |
| EP-1641742-A2 | COMPOUNDS THAT SELECTIVELY BIND TO MEMBRANES OF APOPTOTIC CELLS | NST Neurosurvival Technologies Ltd. (IL) | 2006-04-05 | — | — | EP | claimed |
| EP-1365813-A4 | ASCORBIC ACID ANALOGS FOR METALLORADIOPHARMACEUTICALS | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2006-03-22 | — | — | EP | claimed |
| EP-1546092-A2 | AGENTS FOR IMAGING AND DIAGNOSTIC METHODS USING THEM | Nst Neurosurvival Technologies Ltd. (IL) | 2005-06-29 | — | — | EP | claimed |
| WO-2004096120-A2 | COMPOUNDS THAT SELECTIVELY BIND TO MEMBRANES OF APOPTOTIC CELLS | NST NEUROSURVIVAL TECHNOLOGIES LTD. (IL) | 2004-11-11 | — | — | WO | claimed |
| US-6713042-B2 | BUFFERING REAGENTS, CHELATING AGENTS AND STABILIZERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | claimed |
| US-20040052727-A1 | Radiolableled selective androgen receptor modulators andtheir use in prostate cancer imaging and therapy | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-03-18 | — | — | US | claimed |
| US-20040053911-A1 | Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2004-03-18 | — | — | US | claimed |
| WO-2003101948-A2 | AGENTS FOR IMAGING AND DIAGNOSTIC METHODS USING THEM | NST NEUROSURVIVAL TECHNOLOGIES LTD. (IL) | 2003-12-11 | — | — | WO | claimed |
| EP-1365813-A2 | ASCORBIC ACID ANALOGS FOR METALLORADIOPHARMACEUTICALS | Bristol-Myers Squibb Pharma Company (US) | 2003-12-03 | — | — | EP | claimed |
| EP-1343758-A1 | SUBSTITUTED BIS-INDOLE DERIVATIVES USEFUL AS CONTRAST AGENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES FOR PRODUCING THEM | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2003-09-17 | — | — | EP | claimed |
| WO-2002067859-A3 | ASCORBIC ACID ANALOGS FOR METALLORADIOPHARMACEUTICALS | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2002-11-28 | — | — | WO | claimed |
| WO-2002067859-A2 | ASCORBIC ACID ANALOGS FOR METALLORADIOPHARMACEUTICALS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-09-06 | — | — | WO | claimed |
| US-20020122769-A1 | Ascorbic acid analogs for metalloradiopharmaceuticals | LANTHEUS MEDICAL IMAGING, INC. | 2002-09-05 | — | — | US | claimed |
| WO-2002038546-A1 | SUBSTITUTED BIS-INDOLE DERIVATIVES USEFUL AS CONTRAST AGENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES FOR PRODUCING THEM | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2002-05-16 | — | — | WO | claimed |
| EP-0998946-A1 | Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2000-05-10 | — | — | EP | claimed |
| WO-2000009169-A1 | NON-PORPHYRIN COMPOUND FOR USE AS A DIAGNOSTICUM AND/OR PHARMACEUTICAL | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2000-02-24 | — | — | WO | claimed |
| EP-4373529-A1 | FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2024-05-29 | — | — | EP | disclosed |
| WO-2001083436-A2 | SMALL TECHNETIUM-99M AND RHENIUM LABELED AGENTS AND METHODS FOR IMAGING TUMORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2001-11-08 | — | — | WO | disclosed |